Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00502957 · ClinicalTrials.gov registry record · NA

Biofeedback Treatment for Functional Constipation

A NA study of Constipation, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT00502957: Completed NA study of Constipation, sponsored by University of California, San Francisco.

NCT00502957 is a NA study of Constipation that has completed, run by University of California, San Francisco. The registered enrollment target is 15 participants, below the 205-participant average among 54 other Constipation trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00502957, a NA study of Constipation, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The purpose of this randomized, controlled trial is to examine how well biofeedback treatment works to improve constipation. The study is comparing two kinds of biofeedback treatment: 1) anorectal-specific biofeedback therapy and 2) generalized biofeedback therapy using relaxation techniques. The study will also examine which medical and psychological factors determine biofeedback success for treating constipation, such as bowel habits, emotional reactions to constipation, and levels of stress and psychological distress.

Conditions Studied

Interventions

  • BEHAVIORAL Biofeedback

Study Locations (1)

California

  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2005-03
Est. Completion 2007-11
Phase NA

What the finished NCT00502957 record still lists

NCT00502957 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 205-participant average among 54 other Constipation trials with a reported enrollment target (93% lower).

The record links to 1 condition, with Constipation appearing as the primary indexed condition, and to 1 intervention - of which Biofeedback is the first listed.

NCT00502957 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00502957 about?

NCT00502957 is a clinical study titled "Biofeedback Treatment for Functional Constipation". The purpose of this randomized, controlled trial is to examine how well biofeedback treatment works to improve constipation. The study is comparing two kinds of biofeedback treatment: 1) anorectal-specific biofeedback therapy and 2) generalized biofeedback therapy using relaxation techniques. The s...

What is the current status of trial NCT00502957?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2005-03. Estimated completion is 2007-11.

What conditions does trial NCT00502957 study?

This clinical trial studies the following conditions: Constipation.

What interventions are being tested in trial NCT00502957?

The interventions under investigation include: Biofeedback (BEHAVIORAL).

Who is sponsoring clinical trial NCT00502957?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00502957 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Constipation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00502957's enrollment target sits among peer trials

15 49th of 54 higher than 6 of 54 other Constipation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Constipation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00502957, the US trial registry maintained by the National Library of Medicine. NCT00502957 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.